Table 1.
Demographic and baseline patient characteristics (N=26)
| Age, y | |
| Median (range) | 53 (23–76) |
|
| |
| Sex, n (%) | |
| Women | 13 (50) |
| Men | 13 (50) |
|
| |
| Race, n (%) | |
| White | 19 (73) |
| Black | 4 (15) |
| Asian | 2 (8) |
| Hispanic | 1 (4) |
|
| |
| ECOGa performance status | |
| 0 | 18 (69) |
| 1 | 8 (31) |
|
| |
| Tumor type, n (%) | |
| Thymoma | 12 (46) |
| B1 | 2 (8) |
| B2 | 7 (27) |
| B3 | 3 (11) |
| Thymic carcinoma | 14 (54) |
|
| |
| Stage at enrolment | |
| IVA | 12 (46) |
| IVB | 14 (54) |
|
| |
| Prior Surgery^ | |
| Radical | 11 (42) |
| Debulking | 2 (8) |
|
| |
| Prior Radiation | 7 (27) |
|
| |
| Prior neoadjuvant or adjuvant chemotherapy | 4 (16) |
a
Eastern Cooperative Oncology Group
^
11 patients had radical surgery including 2 who underwent debulking subsequently